Kreztel 20 Tablet contains Telmisartan 20 mg, an angiotensin II receptor antagonist primarily indicated for the treatment of hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor, Telmisartan promotes vasodilation, thereby reducing peripheral vascular resistance and lowering blood pressure. This mechanism helps prevent complications associated with elevated blood pressure, such as stroke, myocardial infarction, and renal impairment. Kreztel 20 is typically prescribed to adults requiring effective long-term blood pressure management, either as monotherapy or in combination with other antihypertensive agents. The tablet is administered orally, with dosage tailored according to patient response and clinical condition. Telmisartan is well-tolerated, with a favorable side effect profile; however, patients should be monitored for potential adverse effects including dizziness, hyperkalemia, and renal function alterations. It is contraindicated in patients with hypersensitivity to Telmisartan or those with severe hepatic impairment. Caution is advised during pregnancy and lactation. Regular blood pressure monitoring and periodic assessment of renal and hepatic function are recommended during therapy. Kreztel 20 Tablet offers a reliable option for managing hypertension, contributing to cardiovascular risk reduction and improved patient outcomes.

Dosage & How to Use